ALPMY – astellas pharma unsp/adr (US:NASDAQ)

News

Astellas Pharma (ALPMY) was upgraded by Jefferies Financial Group Inc. from "hold" to "strong-buy".
IsomAb appoints Dr Philip Brainin as Chief Executive Officer [Yahoo! Finance]
JAMP Pharma Group Expands Oncology Portfolio with PrJAMP Enzalutamide [Yahoo! Finance]
BioNTech's Founding Duo Will Leave to Start New mRNA Firm [Yahoo! Finance Canada]
BioNTech's Founding Duo Will Leave to Start New mRNA Firm [Yahoo! Finance]
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com